©The Author(s) 2025.
World J Crit Care Med. Dec 9, 2025; 14(4): 103782
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.103782
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.103782
Table 2 Friedman test results for the change in functional independence measure motor score values of patients before and after the intervention
| n | Mean | SD | Mean rank | χ2 | df | P value | |
| Preoperative | 5 | 46.20 | 16.39 | 1.40 | 24.883 | 5 | 0.000 |
| Postoperative 1st week | 5 | 46.60 | 16.23 | 1.60 | |||
| Postoperative 1st month | 5 | 52.00 | 17.01 | 3.00 | |||
| Postoperative 2nd month | 5 | 55.20 | 17.81 | 4.00 | |||
| Postoperative 4th month | 5 | 58.80 | 18.95 | 5.00 | |||
| Postoperative 12th month | 5 | 64.20 | 18.90 | 6.00 |
- Citation: Kabatas S, Civelek E, Savrunlu EC, Kaplan N, Akkoc T, Küçükçakır N, Bozkurt M, Karaöz E. Efficacy and safety of exosomes from Wharton’s Jelly-derived mesenchymal stem cells in traumatic brain injury. World J Crit Care Med 2025; 14(4): 103782
- URL: https://www.wjgnet.com/2220-3141/full/v14/i4/103782.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v14.i4.103782